Search for: "Cephalon Inc." Results 41 - 60 of 151
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Sep 2007, 3:04 pm
This medication, made by the drug company Cephalon, Inc., is prescribed to treat patients with excessive sleepiness (ES) associated with narcolepsy, obstructive sleep apnea / hypopnea syndrome (OSAHS), and shift work sleep disorder. [read post]
10 Aug 2006, 2:59 pm
The Food and Drug Administration recently rejected approval of Cephalon Inc.'s newest drug Sparlon, an attention deficit/hyperactivity disorder drug, after it was found to trigger Stevens-Johnson Syndrome (SJS), a serve allergic reaction that often times is fatal. [read post]
28 Aug 2017, 10:11 pm by Barry Barnett
Cephalon, Inc., No. 06-c-1797, ECF 1072 (E.D. [read post]
28 Aug 2017, 10:11 pm by Barry Barnett
Cephalon, Inc., No. 06-c-1797, ECF 1072 (E.D. [read post]
3 Oct 2013, 7:07 am by Docket Navigator
Cephalon, Inc. et. al., 2-06-cv-02768 (PAED October 1, 2013, Order) (Goldberg, J.) [read post]
26 Feb 2010, 4:43 pm by Oklahoma City Attorney
  In response to the growing need for help with these conditions, Cephalon, Inc. formulated and obtained approval from the FDA to market a drug known as Provigil. [read post]
2 Sep 2009, 4:02 am
Actiq is a powerful narcotic painkiller in the form of a lollipop that is manufactured by Cephalon, Inc. [read post]
9 Jan 2022, 8:31 pm by James Kwong
   Patents In the United States, PatentlyO reported that Apotex Inc. recently issued a petition for writ of certiorari in the case of Apotex Inc. v Cephalon, Inc., asking the Supreme Court to revisit motivation to combine, obvious to try and whether the non-obvious contribution needs to be an improvement over the prior art. [read post]
11 Jan 2009, 8:25 pm
Impax Laboratories Inc.1:09-cv-00018; filed January 7, 2009 in the District Court of DelawareInfringement of U.S. [read post]
27 Sep 2009, 9:25 pm
Eurand Inc. et al. v. [read post]
1 Dec 2008, 3:33 am
Patent No. 7,387,793 ("Modified Release Dosage Forms of Skeletal Muscle Relaxants," issued July 17, 2008), licensed to Cephalon, following a Paragraph... [read post]